Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
HOXC6 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
EIF2AK4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ITPR1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
COX5B - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LOC100996809 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
HTATSF1P2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
LOC101928403 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CYP3A4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
NCOA2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
KDM4B - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
NRIP1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FRAS1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
REST - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SHPK - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RHOU - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
C2orf40 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on